PTX 7.14% 3.9¢ prescient therapeutics limited

Ann: FDA Grants Orphan Drug Designation for PTX-200 in AML, page-7

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Interesting...., looking through lists of others lucky enough to obtain the orphan grant and many have sponsors ( licensing deals)
    Also news to me, it appears that, in previous deals made, big pharma have spent more on these specialised drugs than on greater population peers.
    Again, well done PTX on putting the PTX-200 on the radar with the current AML study.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.003(7.14%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $75.11K 1.897M

Buyers (Bids)

No. Vol. Price($)
2 355874 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 75 1
View Market Depth
Last trade - 15.59pm 19/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.